Announce Date | 07/23/2025 |
EPS Normalized Actual | $108.54 (Beat by $3.65) |
EPS GAAP Actual | $108.54 (Beat by $3.65) |
Revenue Actual | $2.54827B |
Revenue Surprise | Beat by $2548.27M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $122.39037 |
EPS GAAP Estimate | $122.39037 |
Revenue Estimate | $2.644413084B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 607.99921 | 13.65 | 583.044 | 637.4916 | 1 |
Dec 2026 | 457.84478 | 18.12 | 423.68934 | 492.00023 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 114.37 | -2.62701 | 2.54827B | -2.52% | -99.18M |
FQ1 2025 (Mar 2025) | 100.41 | 100.41 | 0B | -INF% | 0M |
FQ4 2024 (Dec 2024) | 147.08 | 147.08 | 2.85121B | 17.52% | 2851.21M |
FQ3 2024 (Sep 2024) | 139.66 | 139.66 | 2.73295B | 5.81% | 2732.95M |
FQ2 2024 (Jun 2024) | 128.21 | 128.21 | 2.61246B | 10.35% | 2612.46M |
FQ1 2024 (Mar 2024) | 116.41 | 116.41 | 2.37842B | 8.29% | 2378.42M |
FQ4 2023 (Dec 2023) | 121.58 | 121.58 | 2.35166B | -6.49% | 2351.66M |
FQ3 2023 (Sep 2023) | 132.92 | 132.92 | 2.57409B | -6.42% | 2574.09M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
122.39037
Consensus Revenue Estimates
2.644413084B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 176.05491 | -- | 168.46333 | 183.28583 | 1 |
FQ3 2027 (Sep 2027) | 165.26356 | -- | 158.1373 | 172.05126 | 1 |
FQ2 2027 (Jun 2027) | 148.65203 | -- | 142.24207 | 154.75746 | 1 |
FQ1 2027 (Mar 2027) | 119.52714 | -- | 114.37306 | 124.43635 | 1 |
FQ4 2026 (Oct 2026) | 137.03123 | -- | 134.05985 | 140.77977 | 1 |
FQ3 2026 (Jul 2026) | 120.99991 | -- | 118.37615 | 124.30991 | 1 |
FQ2 2026 (Jun 2026) | 109.01615 | -4.91 | 101.99012 | 114.98513 | 1 |
FQ1 2026 (Mar 2026) | 93.5927 | -7.28 | 87.56071 | 98.7172 | 1 |
FQ4 2025 (Oct 2025) | 133.85927 | -9.88 | 130.95667 | 137.52104 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 3.3B | -- | 3.19B | 3.4B | 1 |
FQ3 2027 (Sep 2027) | 3.19B | -- | 3.08B | 3.29B | 1 |
FQ2 2027 (Jun 2027) | 2.99B | -- | 2.89B | 3.09B | 1 |
FQ1 2027 (Mar 2027) | 2.57B | -- | 2.49B | 2.65B | 1 |
FQ4 2026 (Oct 2026) | 2.92B | -- | 2.88B | 2.99B | 1 |
FQ3 2026 (Jul 2026) | 2.7B | -- | 2.66B | 2.76B | 1 |
FQ2 2026 (Jun 2026) | 2.66B | 4.25 | 2.53B | 2.77B | 2 |
FQ1 2026 (Mar 2026) | 2.32B | -- | 2.2B | 2.42B | 2 |
FQ4 2025 (Oct 2025) | 2.84B | -0.4 | 2.79B | 2.9B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
1
Revenue # of in-lines
1
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 116.99701 | 114.37 | -2.62701 | -2.3% |
FQ1 2025 (Mar 2025) | 100.41 | 100.41 | 100% | |
FQ4 2024 (Dec 2024) | 147.08 | 147.08 | 100% | |
FQ3 2024 (Sep 2024) | 139.66 | 139.66 | 100% | |
FQ2 2024 (Jun 2024) | 128.21 | 128.21 | 100% | |
FQ1 2024 (Mar 2024) | 116.41 | 116.41 | 100% | |
FQ4 2023 (Dec 2023) | 121.58 | 121.58 | 100% | |
FQ3 2023 (Sep 2023) | 132.92 | 132.92 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $2.65B | $2.55B | $-99.18M | -3.89% |
FQ1 2025 (Mar 2025) | $0B | $0B | $0M | NAN% |
FQ4 2024 (Dec 2024) | $0B | $2.85B | $2851.21M | 100% |
FQ3 2024 (Sep 2024) | $0B | $2.73B | $2732.95M | 100% |
FQ2 2024 (Jun 2024) | $0B | $2.61B | $2612.46M | 100% |
FQ1 2024 (Mar 2024) | $0B | $2.38B | $2378.42M | 100% |
FQ4 2023 (Dec 2023) | $0B | $2.35B | $2351.66M | 100% |
FQ3 2023 (Sep 2023) | $0B | $2.57B | $2574.09M | 100% |